Recent Publications by Pharmaceutical Profiles: |
An in vitro study to assess facial and ocular deposition from Respimat Soft Mist inhaler.
Respimat Soft Mist() inhaler (SMI) is a novel multidose propellant-free... | 5th May, 2007
| Pharmaceutical Profiles Ltd, Nottingham, UK.
| J Aerosol Med. 2007 Spring;20(1):7-12.
DOI Direct Link |
High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma.
OBJECTIVE: To examine the deposition and pharmacokinetics of ciclesonide... | 30th August, 2006
| Pharmaceutical Profiles, Nottingham, UK.
| Respir Med. 2006 Mar;100(3):375-84. Epub 2005 Nov 4.
DOI Direct Link |
Improved early clinical development through human microdosing studies.
The pressurized metered-dose inhaler (pMDI) was introduced to deliver... | 25th May, 2006
| Pharmaceutical Profiles, Mere Way, Ruddington Fields, Nottingham NG11 6JS,
| Drug Discov Today. 2005 Jul 1;10(13):890-4.
DOI Direct Link |
Principles of metered-dose inhaler design.
The pressurized metered-dose inhaler (pMDI) was introduced to deliver... | 15th December, 2005
| Pharmaceutical Profiles Ltd, Nottingham, United Kingdom.
| Respir Care. 2005 Sep;50(9):1177-90.
|
Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
Fourteen mild-to-moderate asthmatic patients completed a randomized... | 11th November, 2005
| Pharmaceutical Profiles Ltd., Nottingham, United Kingdom.
| J Aerosol Med. 2005 Fall;18(3):264-72.
DOI Direct Link |
The Novolizer: a multidose dry powder inhaler: a viewpoint by Stephen P. Newman.
The pressurized metered-dose inhaler (pMDI) was introduced to deliver... | 1st July, 2005
| Pharmaceutical Profiles Ltd, Nottingham, UK.
| Treat Respir Med. 2005;4(1):70.
|
In vivo disintegration profiles of encapsulated and nonencapsulated sumatriptan: gamma scintigraphy in healthy volunteers.
The goal of this exploratory pilot study was to use gamma scintigraphy to... | 9th April, 2005
| Pharmaceutical Profiles, Ltd, Nottingham, United Kingdom.
| J Clin Pharmacol. 2005 Jan;45(1):101-5.
DOI Direct Link |
Spacer devices for metered dose inhalers.
Spacer devices are attachments to the mouthpieces of pressurised metered... | 28th July, 2004
| Pharmaceutical Profiles Ltd, Ruddington, Nottingham, UK.
| Clin Pharmacokinet. 2004;43(6):349-60.
|
Remote controlled capsules in human drug absorption (HDA) studies.
The biopharmaceutical complexity of today's new drug candidates provides... | 21st July, 2004
| Pharmaceutical Profiles Ltd., Ruddington Fields, Ruddington, Nottingham,
| Crit Rev Ther Drug Carrier Syst. 2003;20(6):405-31.
|
Dry powder inhalers for optimal drug delivery.
Dry powder inhalers (DPIs) have been available for delivering drugs to the... | 21st July, 2004
| Pharmaceutical Profiles Ltd, Mere Way, Ruddington Fields, Nottingham NG11
| Expert Opin Biol Ther. 2004 Jan;4(1):23-33.
DOI Direct Link |
Drug delivery to the nasal cavity: in vitro and in vivo assessment.
Drugs are given intranasally for both local and systemic applications, and... | 1st July, 2004
| Pharmaceutical Profiles Ltd., Mere Way, Ruddington Fields, Nottingham NG11
| Crit Rev Ther Drug Carrier Syst. 2004;21(1):21-66.
|
Deposition and effects of inhaled corticosteroids.
Inhaled corticosteroids are now recommended as maintenance therapy for all... | 21st June, 2004
| Pharmaceutical Profiles Ltd, Ruddington, Nottingham, UK.
| Clin Pharmacokinet. 2003;42(6):529-44.
|
Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy.
PURPOSE: To determine the bioavailability and pharmacokinetic profile of... | 9th April, 2004
| Pharmaceutical
| Pharm Res. 2004 Mar;21(3):443-6.
|
Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs.
Whole lung and regional lung deposition of inhaled asthma drugs in the... | 16th January, 2004
| Pharmaceutical Profiles Ltd, Mere Way, Ruddington Fields, Ruddington,
| Adv Drug Deliv Rev. 2003 Jul 18;55(7):851-67.
|
Drug delivery to the lungs from dry powder inhalers.
When asthma is being treated, it is essential that sufficient drug is... | 13th November, 2003
| Pharmaceutical Profiles Ltd, Mere Way, Ruddington Fields, Ruddington,
| Curr Opin Pulm Med. 2003 Apr;9 Suppl 1:S17-20.
|
